OneVector Insights
GxP AI, validation, and life sciences IT insights
Practical perspectives on regulated AI, computer system validation, pharmacovigilance, compliance, and technology strategy.
Transforming Pharmacovigilance with AI, RWE & Responsible Innovation
From Automation to Accountable AI In my previous article - Future-fit Pharmacovigilance, I examined why inspection findings and FDA 483 observations are increasingly linked to process gaps, inadequate oversight, and weak digital governance in pharmacovigilance.
Blogs
4 posts
ICH E6 (R3) - Data Governance and Computer System Validation considerations for Sponsors!
The International Council for Harmonization (ICH) has released the revised Guideline for Good Clinical Practice, E6(R3). This update introduces important clarifications and expectations relevant to Compliance functions, particularly in the areas of Data Governance and Computerized Systems.
AI Is the New Baseline — Ignore It and Risk Being Flat-Footed
When observing the biotech landscape, it is clear that AI is poised to disrupt the industry — if it hasn't already — by driving meaningful productivity gains through everyday tools used across functions.
Developing an AI Roadmap for Small-Mid Size Biotech
Several large pharma and biotech's are using AI for productivity and value creation. However, for small- to mid-sized biotech's, the primary focus and resources are allocated to achieving positive clinical outcomes. To avoid falling behind, Executive Leadership Teams are executing focused AI initiatives.
2025 Year-End Reflection — Doing More with Less
The Life Sciences technology landscape feels both familiar and fundamentally changed. Across emerging biotech, mid-cap innovators, and global pharmaceutical organizations, three forces reshaped priorities this year: resource discipline, technology partnerships that deliver real outcomes, and an embrace of intelligence and compliance.
Articles
5 articles
Transforming Pharmacovigilance with AI, RWE & Responsible Innovation
From Automation to Accountable AI In my previous article - Future-fit Pharmacovigilance, I examined why inspection findings and FDA 483 observations are increasingly linked to process gaps, inadequate oversight, and weak digital governance in pharmacovigilance.
Future-Fit Pharmacovigilance: Compliance Strategies for the Digital Pharmacovigilance Era
Pharmacovigilance (PV) compliance today is no longer just about avoiding regulatory citations - it's about building a resilient, intelligent safety ecosystem that protects patients and products, it is existential. As FDA inspections sharpen their focus on data integrity, real-time reporting, and digital compliance, life sciences must transition from reactive compliance to proactive safety governance.
CSV Evolution: How We Slashed 14,000+ Test Steps Without Missing a Beat
"True CSV excellence isn't measured by the number of pages in your OQ, but by the clarity of your risk-based thinking."
Computer System Validation (CSV) – thought process & the importance!
Computer systems are everywhere in the Medical Devices and Pharma world. From design and manufacturing to post-market surveillance, they quietly power almost every step in the value chain. And validating those systems? That’s not optional - it’s essential.
Can Agile SDLC and GxP Computer System Validation Coexist? Yes—Here’s How We’ve Made It Work
This article explores practical strategies to bridge the gap between Agile Software Development Lifecycle (SDLC) and GxP Computer System Validation (CSV), based on real-life implementation at a biotech startup developing custom AI-based clinical trial automation software.
Case Studies
7 studies
Establishing a secure & scalable IT Infrastructure for a Biotech Company
Client was a small-sized biotech company having a dedicated platform designed to engineer a new class of gene therapies for a wide range of diseases. To achieve this, they want to establish a secure, compliant, and scalable IT infrastructure, enabling the client to focus on scientific innovation while deferring the cost of a full-time internal IT department.
IT Roadmap: Transforming IT in Anticipation of Commercial Launch
Even the most established and well-functioning IT departments at early-stage Life Sciences organizations can be caught off-guard by good news from the clinic. With the likelihood of a commercial company now a very real possibility, these IT organizations need to transform themselves to align with new and urgent business imperatives and regulatory compliance requirements.
IT Advisory for Regulatory & Operational Efficiency
Our client, a prominent life sciences company, embarked on implementing Veeva Systems to elevate their regulatory compliance and operational efficiency. They entrusted One Vector to oversee the project management aspect, ensuring seamless deployment aligned with industry standards.
Demonstrating One Vector's Expertise in IT Portfolio Management for Emerging Cell & Gene Therapy Organizations
Our client, a large Contract Manufacturing Organization (CMO), is building a plant that specializes in Cell & Gene Therapy (C>) technologies. They entrusted One Vector to manage all IT projects related to the qualification and commercial approval of the site, ensuring their ability to honor commitments to regulatory authorities and to manufacture life-saving therapies for their customers
Demonstrating Excellence in Computer System Validation for a Life Sciences Manufacturing Lab
A rapidly expanding life sciences manufacturing laboratory, specializing in innovative therapeutic products, required a robust framework to ensure their computer systems meet stringent regulatory demands. To address this need, One Vector team provided comprehensive Computer System Validation (CSV) services, aligning all computerized systems with required FDA regulations and prevailing industry standards. This initiative not only ensured full regulatory compliance but also significantly enhanced operational efficiency and safeguarded data integrity across the organization's digital infrastructure ensuring audit readiness.
Cloud Infrastructure Qualification Program for Migration of GxP Applications
Our client, a fast-growing Biotech company, embarked on transitioning their applications from an On-premises environment to Cloud Infrastructure set up. The applications were GAMP category 5 custom solutions and required adherence to specific compliance requirements. Client was expecting an inspection from the regulatory body and were preparing for same. The engagement scope was AWS cloud qualification for migration of the GAMP category 5 applications.
Audit Readiness of Clinical Trial IT Systems for EU Inspection
A mid-sized biotech company focused on utilizing engineered cells as medicines for patients across various therapeutic areas, including diabetes and oncology. To achieve this they required full IT system readiness and compliance with EU regulations for a clinical trial testing and manufacturing site within an aggressive 90-day window.
Where to Find Us
Connect with One Vector at the industry’s leading conferences, summits and speaker sessions.
25th Bio-IT World Conference & Expo
Breakthroughs in AI, data science, and IT infrastructure powering life sciences.
Analytical Quality & Control — Laboratory University
Attend the following insightful sessions by One Vector Experts at KENX Laboratory University - 1. "Computer Software Assurance in the Real World: Validating Complex Digital Supply Chain Ecosystems — Lessons from applying CSA to serialization platforms, supplier portals, and integrated logistics systems” presented by Keyur Doshi, Senior Director Compliance Services 2. "Harnessing AI to Automate Quality and Compliance Tasks: Transforming documentation, review, and inspection readiness, presented by Binesh Prabhakar, Founder One Vector With two full tracks – Analytical Procedures & QC Excellence and Stability Testing Program Management – this event by KENX delivers deep technical training, regulatory insight, and practical solutions for life-science laboratories. Meet with our experts at KENX or contact us to learn more about the topic of your interest.
DIA 2026 Global Annual Meeting
One Vector Team is participating in the premier conference and presenting a point of view poster " Future Fit Pharmacovigilance - Deploying AI and ML Under Regulated Environment" at DIA 2026. DIA is a premier event shaping the future of health product development where global leaders, innovators, regulators, academics, and patient advocates meet annually. As the life sciences industry continues to evolve, this event serves as a powerful platform to connect, collaborate, and drive forward transformative solutions.
42nd SQA Annual Meeting & Quality College
"QA Foundations and Frontiers: Your Compass for Quality" — engaging with quality leaders.
18th Annual Outsourcing in Clinical Trials West Coast
Connecting with industry leaders driving innovation in clinical trial outsourcing and operations.
ISPE CaSA Tech Show Raleigh
Engaging with pharmaceutical engineering professionals on digital-first validation and compliance strategies.
Lab of the Future Congress
Exploring innovations in digital transformation, AI-driven lab operations, data strategy, and connected lab technologies.
RAPS Global Regulatory Strategy Conference
Engaging with regulatory affairs leaders on AI-driven compliance and evolving regulatory frameworks.
ISPE Boston — Risk-Based Validation Panel
Panel discussion: "Breaking the Bottleneck — A Risk-Based, Digital-First Approach to Validation."
KENX Pharmaceutical Engineering Summit
Integrating process, automation, and facility excellence in pharmaceutical manufacturing.